摘要
为了规范和更新丙型肝炎的预防、诊断和抗病毒治疗,实现世界卫生组织提出的"2030年消除病毒性肝炎作为公共卫生威胁"目标,中华医学会肝病学分会和感染病学分会于2019年组织国内有关专家,以国内外丙型肝炎病毒感染的基础、临床和预防研究进展为依据,结合现阶段我国的实际情况,更新形成了《丙型肝炎防治指南(2019年版)》,为丙型肝炎的预防、诊断和治疗提供重要依据。
In order to standardize and update the prevention,diagnosis and antiviral therapy of hepatitis C and to achieve the World Health Organization's goal of eliminating viral hepatitis as a public health threat by 2030,Chinese Medical Association,the Chinese Society of Hepatology,and the Society of Infectious Diseases organized relevant native experts in 2019 to revise the guideline for the prevention and treatment of hepatitis C(2019 version)based on the basic,clinical and prophylactic research progress of hepatitis C infection at home and abroad,combined with the present actual situation of our country,so as to provide an important basis for the prevention,diagnosis and treatment of hepatitis C.
作者
无
魏来
段钟平
王贵强
无;Wei Lai;Duan Zhongping;Wang Guiqiang(Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Infectious Diseases,Chinese Medical Association;Hepatopancreatobiliary Center,Beijing Tsinghua Changgung Hospital,Tsinghua University,Beijing 102218,China;Difficult&Complicated Liver Diseases and Artificial Liver Center,Beijing Youan Hospital,Capital Medical University,Beijing 100069,China;Department of Infectious Diseases and Center for Liver Diseases,Peking University First Hospital,Department of Infectious Diseases and Liver Diseases,Peking University International Hospital,Beijing 100034,China)
出处
《国际流行病学传染病学杂志》
CAS
2019年第6期447-465,共19页
International Journal of Epidemiology and Infectious Disease
关键词
肝炎
丙型
治疗
预防
指南
直接抗病毒药物
Hepatitis C
Treatment
Prevention
Guideline
Direct antiviral agent
